Endonovo Therapeutics (OTCMKTS:ENDV) vs. QT Imaging (NASDAQ:QTI) Head-To-Head Analysis

Endonovo Therapeutics (OTCMKTS:ENDVGet Free Report) and QT Imaging (NASDAQ:QTIGet Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Profitability

This table compares Endonovo Therapeutics and QT Imaging’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Endonovo Therapeutics 4,911.97% -29.58% 755.18%
QT Imaging N/A N/A -19.75%

Earnings & Valuation

This table compares Endonovo Therapeutics and QT Imaging’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Endonovo Therapeutics $140,000.00 2.55 $6.93 million N/A N/A
QT Imaging N/A N/A -$4.03 million N/A N/A

Endonovo Therapeutics has higher revenue and earnings than QT Imaging.

Analyst Recommendations

This is a summary of current recommendations and price targets for Endonovo Therapeutics and QT Imaging, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Endonovo Therapeutics 0 0 0 0 N/A
QT Imaging 0 0 0 0 N/A

Risk & Volatility

Endonovo Therapeutics has a beta of -1.96, indicating that its share price is 296% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500.

Insider & Institutional Ownership

24.2% of QT Imaging shares are held by institutional investors. 5.6% of Endonovo Therapeutics shares are held by company insiders. Comparatively, 75.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

About Endonovo Therapeutics

(Get Free Report)

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

About QT Imaging

(Get Free Report)

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.